A global platform for translational medicine, guided by scientific integrity and international collaboration.
NBIIC is developing a clinical collaboration platform to connect international patients, researchers, clinicians, and medical institutions with selected innovative clinical technologies.
Some of these technologies are available through leading medical institutions and approved innovation programs, including the Boao Lecheng International Medical Tourism Pilot Zone in China.
This section provides an overview of selected clinical technology areas for professional reference and future collaboration.
Selected innovative clinical technologies cover a broad range of disease areas, including regenerative medicine, oncology, cardiovascular diseases, autoimmune disorders, neurological diseases, ophthalmology, respiratory diseases, women's health, and other clinical fields.
Cell-based and regenerative approaches for musculoskeletal conditions.
Innovative cellular, immune, and targeted clinical technologies.
Clinical technologies related to vascular repair, cardiac function, and related conditions.
Innovative approaches for immune-mediated diseases and inflammatory disorders.
Selected technologies for neurodegenerative and neurological conditions.
Clinical technologies for selected pulmonary and respiratory conditions.
Innovative technologies for vision-related diseases.
Selected technologies for reproductive and gynecological conditions.
The following overview summarizes selected innovative clinical technologies available through approved clinical translation programs and collaborating medical institutions. These technologies cover multiple disease areas, including regenerative medicine, oncology, cardiovascular diseases, autoimmune disorders, liver diseases, neurological disorders, ophthalmology, and other clinical fields.
For professional reference only. All clinical decisions and patient eligibility assessments must be made by qualified medical professionals and participating institutions.
Patients, families, clinicians, or partner institutions may submit an initial inquiry.
Relevant clinical information and medical records are reviewed by qualified professionals.
Appropriate specialists or partner institutions may provide professional evaluation.
NBIIC may help coordinate communication with suitable medical institutions or clinical partners.
Any clinical arrangement must be determined by licensed medical professionals and participating institutions.
Where appropriate, NBIIC may support follow-up communication, research collaboration, or international academic exchange.
The information provided on this page is for professional reference and international collaboration purposes only. It does not constitute medical advice, diagnosis, treatment recommendation, or a guarantee of eligibility for any specific clinical technology. All clinical decisions must be made by qualified medical professionals based on individual patient conditions and applicable regulations.